WUXIDARX Trademark

Trademark Overview

On Wednesday, October 11, 2023, a trademark application was filed for WUXIDARX with the United States Patent and Trademark Office. The USPTO has given the WUXIDARX trademark a serial number of 98218315. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 15, 2024. This trademark is owned by WUXI XDC SINGAPORE PRIVATE LIMITED. The WUXIDARX trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom assembling of materials, namely, custom assembling of antibody drug conjugates and intermediates thereof for others; Custom manufacturing of pharmaceuticals; Custom manufacturing of drug conjugates; Customized production service of pharmaceuticals; Customized production service of biological preparations; Custom manufacturing of Antibody-drug Conjugates; Processing and treating of chemical reagents, namely, custom production of reagents for scientific or medical research use; Pharmaceutical processing, namely, processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; Processing of biomedical preparations for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of chemical materials for production of drug conjugates for others

Development of new products for others; pharmaceutical drug development service; Research and development of new products; Biochemical research and development; Custom design and development of chemical reagent antibodies and conjugate antibodies; Research and development in the field of pharmaceutical biomedicine and biotechnology, namely, research of antibodies, namely, conjugated antibodies; Biomedical research services; Development of pharmaceutical preparations and medicines; Research and development of Antibody-drug Conjugates; Research and development of drug conjugates
wuxidarx

General Information

Serial Number98218315
Word MarkWUXIDARX
Filing DateWednesday, October 11, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements

Goods and ServicesCustom assembling of materials, namely, custom assembling of antibody drug conjugates and intermediates thereof for others; Custom manufacturing of pharmaceuticals; Custom manufacturing of drug conjugates; Customized production service of pharmaceuticals; Customized production service of biological preparations; Custom manufacturing of Antibody-drug Conjugates; Processing and treating of chemical reagents, namely, custom production of reagents for scientific or medical research use; Pharmaceutical processing, namely, processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; Processing of biomedical preparations for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of chemical materials for production of drug conjugates for others
Goods and ServicesDevelopment of new products for others; pharmaceutical drug development service; Research and development of new products; Biochemical research and development; Custom design and development of chemical reagent antibodies and conjugate antibodies; Research and development in the field of pharmaceutical biomedicine and biotechnology, namely, research of antibodies, namely, conjugated antibodies; Biomedical research services; Development of pharmaceutical preparations and medicines; Research and development of Antibody-drug Conjugates; Research and development of drug conjugates

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWUXI XDC SINGAPORE PRIVATE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
Address100 AM SINGAPORE 079027
SG
Party NameWUXI XDC SINGAPORE PRIVATE LIMITED
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
Address100 AM SINGAPORE 079027
SG

Trademark Events

Event DateEvent Description
Saturday, October 14, 2023NEW APPLICATION ENTERED
Monday, October 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 29, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024ASSIGNED TO EXAMINER
Wednesday, July 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

wuxidarx development research drug custom conjugates processing others manufacturing pharmaceutical namely